Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial | ADC Fetal & Neonatal Edition

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Original research

Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

	Abstract	Full	Pdf
Jun 2021	336	333	125
Jul 2021	187	185	94
Aug 2021	109	109	48
Sep 2021	115	114	51
Oct 2021	427	431	102
Nov 2021	554	553	148
Dec 2021	466	468	69
Jan 2022	310	309	50
Feb 2022	109	104	39
Mar 2022	185	182	52
Apr 2022	201	205	58
May 2022	188	195	49
Jun 2022	224	222	62
Jul 2022	151	156	56
Aug 2022	158	148	43
Sep 2022	198	195	55
Oct 2022	261	245	46
Nov 2022	264	267	25
Dec 2022	234	232	44
Jan 2023	223	226	62
Feb 2023	268	273	43
Mar 2023	286	293	42
Apr 2023	251	248	65
May 2023	329	331	68
Jun 2023	350	342	83
Jul 2023	285	290	65
Aug 2023	343	338	38
Sep 2023	371	359	48
Oct 2023	305	301	70
Nov 2023	238	244	38
Dec 2023	178	139	33
Jan 2024	47	40	28
Feb 2024	134	117	53
Mar 2024	246	239	56
Total	8531	8433	2008